TACROLIMUS OINTMENT 0.1% and PYREXIA

3,681 reports of this reaction

2.0% of all TACROLIMUS OINTMENT 0.1% reports

#9 most reported adverse reaction

Overview

PYREXIA is the #9 most commonly reported adverse reaction for TACROLIMUS OINTMENT 0.1%, manufactured by Encube Ethicals, Inc.. There are 3,681 FDA adverse event reports linking TACROLIMUS OINTMENT 0.1% to PYREXIA. This represents approximately 2.0% of all 181,625 adverse event reports for this drug.

TACROLIMUS OINTMENT 0.1% has an overall safety score of 92 out of 100. Patients taking TACROLIMUS OINTMENT 0.1% who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA3,681 of 181,625 reports

PYREXIA is a less commonly reported adverse event for TACROLIMUS OINTMENT 0.1%, but still significant enough to appear in the safety profile.

Other Side Effects of TACROLIMUS OINTMENT 0.1%

In addition to pyrexia, the following adverse reactions have been reported for TACROLIMUS OINTMENT 0.1%:

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

ABACAVIR SULFATEACALABRUTINIBACETAMINOPHENACETAMINOPHEN 325MGACETAMINOPHEN 500MGACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HBRACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN TABLET EXTENDED RELEASEACETYLCYSTEINEACYCLOVIRACYCLOVIR SODIUM

Frequently Asked Questions

Does TACROLIMUS OINTMENT 0.1% cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,681 FDA reports for TACROLIMUS OINTMENT 0.1%. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with TACROLIMUS OINTMENT 0.1%?

PYREXIA accounts for approximately 2.0% of all adverse event reports for TACROLIMUS OINTMENT 0.1%, making it a notable side effect.

What should I do if I experience PYREXIA while taking TACROLIMUS OINTMENT 0.1%?

If you experience pyrexia while taking TACROLIMUS OINTMENT 0.1%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

TACROLIMUS OINTMENT 0.1% Full ProfileAll Drugs Causing PYREXIAEncube Ethicals, Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.